Creative Medical Technology Holdings, Inc. (CELZ)

Market Cap	7.35M
Revenue (ttm)	137,754
Net Income (ttm)	-7.80M
Shares Out	14.08M
EPS (ttm)	-4.61
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	183,824
Open	0.570
Previous Close	0.553
Day's Range	0.498 - 0.570
52-Week Range	0.330 - 5.145
Beta	4.90
Analysts	Buy
Price Target	10.20 (+1,853.65%)
Earnings Date	n/a

About CELZ

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 4
• Stock Exchange: NASDAQ
• Ticker Symbol: CELZ

Analyst Forecast

According to 7 analysts, the average rating for CELZ stock is "Buy." The 12-month stock price forecast is $10.2, which is an increase of 1,853.65% from the latest price.

Price Target

$10.2

(1,853.65% upside)

Analyst Consensus: Buy